Clinical Trial Update: A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II study evaluating azacitidine (Vidaza) in combination with nab-paclitaxel (Abraxane) in patients with advanced or metastatic solid tumors and metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Or Metastatic Solid Tumors

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: University of Utah | Conditions: Advanced or Metastatic Solid Tumors, Advanced or Metastatic Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-26